The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

• Juan-Carlos Hernández-Boluda,
• Arturo Pereira,
• Montse Gómez,
• Concepción Boqué,
• Francisca Ferrer-Marín,
• José-María Raya,
• Valentín García-Gutiérrez,
• Ana Kerguelen,
• Blanca Xicoy,
• Pere Barba,
• Jesús Martínez,
• Elisa Luño,
• Alberto Alvarez-Larrán,
• Joaquín Martínez-López,
• Elisa Arbelo,
• Carles Besses

Affiliations

Juan-Carlos Hernández-Boluda

Hematology and Medical Oncology Department, Hospital Clínico Universitario, Valencia

Arturo Pereira

Hemotherapy and Hemostasis Department, Hospital Clínic, Barcelona

Montse Gómez

Hematology and Medical Oncology Department, Hospital Clínico Universitario, Valencia

Concepción Boqué

Hematology Department, Institut Català d’Oncologia, Hospitalet de Llobregat, Barcelona

Francisca Ferrer-Marín

Hematology and Medical Oncology Department, Hospital Morales Meseguer, Murcia

José-María Raya

Hematology Department, Hospital Universitario de Canarias, La Laguna

Valentín García-Gutiérrez

Hematology Department, Hospital Ramón y Cajal, Madrid

Ana Kerguelen

Hematology Department, Hospital La Paz, Madrid

Blanca Xicoy

Clinical Hematology Department, Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research, Badalona

Pere Barba

Hematology Department, Hospital Vall d’Hebron, Barcelona

Jesús Martínez

Hematology Department, Hospital La Fe, Valencia

Elisa Luño

Hematology Department, Hospital Universitario Central de Asturias, Oviedo

Alberto Alvarez-Larrán

Hematology Department, Hospital del Mar-IMIM, Barcelona

Joaquín Martínez-López

Hematology Department, Hospital 12 de Octubre, Madrid

Elisa Arbelo

Hematology Department, Hospital Virgen de la Macarena, Sevilla, Spain

Carles Besses

Hematology Department, Hospital del Mar-IMIM, Barcelona